Skip to main content
Colleen Annesley, MD, Pediatric Hematology & Oncology, Seattle, WA

ColleenElizabethAnnesleyMD

Pediatric Hematology & Oncology Seattle, WA

Assistant Professor, Seattle Children's Hospital, University of Washington

Dr. Annesley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Annesley's full profile

Already have an account?

  • Office

    4800 Sand Point Way NE
    Cancer and Blood Disorders Center, Seattle Children's Hospital
    Seattle, WA 98145
    Phone+1 206-987-7122
    Fax+1 206-987-3946

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Pediatrics, 2006 - 2009
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2006

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2015 - 2026
  • MD State Medical License
    MD State Medical License 2009 - 2016
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Beyond the Storm — Subacute Toxicities and Late Effects in Children Receiving CAR T Cells
    Beyond the Storm — Subacute Toxicities and Late Effects in Children Receiving CAR T CellsJanuary 25th, 2021
  • Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood Cancers
    Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 5th, 2021
  • 22-Year-Old College Student Beats Leukemia, Returns to School After Successful Cancer Treatment for Young Adults at Seattle Children’s
    22-Year-Old College Student Beats Leukemia, Returns to School After Successful Cancer Treatment for Young Adults at Seattle Children’sJuly 13th, 2023